Cargando…

Drug candidates targeting multidrug resistance in cancer and infections

Detalles Bibliográficos
Autores principales: Le Borgne, Marc, Falson, Pierre, Boumendjel, Ahcène
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Published by Elsevier Masson SAS. 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9892329/
https://www.ncbi.nlm.nih.gov/pubmed/36738554
http://dx.doi.org/10.1016/j.ejmech.2023.115173
_version_ 1784881308449636352
author Le Borgne, Marc
Falson, Pierre
Boumendjel, Ahcène
author_facet Le Borgne, Marc
Falson, Pierre
Boumendjel, Ahcène
author_sort Le Borgne, Marc
collection PubMed
description
format Online
Article
Text
id pubmed-9892329
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Published by Elsevier Masson SAS.
record_format MEDLINE/PubMed
spelling pubmed-98923292023-02-02 Drug candidates targeting multidrug resistance in cancer and infections Le Borgne, Marc Falson, Pierre Boumendjel, Ahcène Eur J Med Chem Article Published by Elsevier Masson SAS. 2023-03-05 2023-02-02 /pmc/articles/PMC9892329/ /pubmed/36738554 http://dx.doi.org/10.1016/j.ejmech.2023.115173 Text en © 2023 Published by Elsevier Masson SAS. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Article
Le Borgne, Marc
Falson, Pierre
Boumendjel, Ahcène
Drug candidates targeting multidrug resistance in cancer and infections
title Drug candidates targeting multidrug resistance in cancer and infections
title_full Drug candidates targeting multidrug resistance in cancer and infections
title_fullStr Drug candidates targeting multidrug resistance in cancer and infections
title_full_unstemmed Drug candidates targeting multidrug resistance in cancer and infections
title_short Drug candidates targeting multidrug resistance in cancer and infections
title_sort drug candidates targeting multidrug resistance in cancer and infections
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9892329/
https://www.ncbi.nlm.nih.gov/pubmed/36738554
http://dx.doi.org/10.1016/j.ejmech.2023.115173
work_keys_str_mv AT leborgnemarc drugcandidatestargetingmultidrugresistanceincancerandinfections
AT falsonpierre drugcandidatestargetingmultidrugresistanceincancerandinfections
AT boumendjelahcene drugcandidatestargetingmultidrugresistanceincancerandinfections